BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 19817029)

  • 1. Role of new chemotherapy agents in soft tissue sarcoma.
    von Mehren M
    J Natl Compr Canc Netw; 2005 Mar; 3(2):198-205. PubMed ID: 19817029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New therapeutic strategies for soft tissue sarcomas.
    von Mehren M
    Curr Treat Options Oncol; 2003 Dec; 4(6):441-51. PubMed ID: 14585225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential combination chemotherapy approaches for advanced adult-type soft-tissue sarcoma.
    Kopp HG; Patel S; Brücher B; Hartmann JT
    Am J Clin Dermatol; 2008; 9(4):207-17. PubMed ID: 18572972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of chemotherapy in patients with soft tissue sarcomas.
    Maki RG
    Expert Rev Anticancer Ther; 2004 Apr; 4(2):229-36. PubMed ID: 15056053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New emerging drugs in soft tissue sarcoma.
    Milano A; Apice G; Ferrari E; Fazioli F; de Rosa V; de Luna AS; Iaffaioli RV; Caponigro F
    Crit Rev Oncol Hematol; 2006 Jul; 59(1):74-84. PubMed ID: 16533604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic pipeline for soft-tissue sarcoma.
    Cassier PA; Labidi-Galy SI; Heudel P; Dutour A; Méeus P; Chelghoum M; Alberti L; Ray-Coquard I; Blay JY
    Expert Opin Pharmacother; 2011 Nov; 12(16):2479-91. PubMed ID: 21913865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent developments in salvage chemotherapy for patients with metastatic soft tissue sarcoma.
    Hartmann JT; Patel S
    Drugs; 2005; 65(2):167-78. PubMed ID: 15631540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy in adult soft tissue sarcoma.
    Jain A; Sajeevan KV; Babu KG; Lakshmaiah KC
    Indian J Cancer; 2009; 46(4):274-87. PubMed ID: 19749457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic treatment options for patients with refractory adult-type sarcoma beyond anthracyclines.
    Hartmann JT
    Anticancer Drugs; 2007 Mar; 18(3):245-54. PubMed ID: 17264755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brostallicin, an agent with potential activity in metastatic soft tissue sarcoma: a phase II study from the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
    Leahy M; Ray-Coquard I; Verweij J; Le Cesne A; Duffaud F; Hogendoorn PC; Fowst C; de Balincourt C; di Paola ED; van Glabbeke M; Judson I; Blay JY;
    Eur J Cancer; 2007 Jan; 43(2):308-15. PubMed ID: 17095209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of single-agent and combination chemotherapy for advanced soft tissue sarcomas. Implications for decision making in the clinic.
    Demetri GD; Elias AD
    Hematol Oncol Clin North Am; 1995 Aug; 9(4):765-85. PubMed ID: 7490240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel treatment strategies for soft tissue sarcoma.
    Kasper B; Gil T; D'Hondt V; Gebhart M; Awada A
    Crit Rev Oncol Hematol; 2007 Apr; 62(1):9-15. PubMed ID: 17141519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigational therapies in phase II clinical trials for the treatment of soft tissue sarcoma.
    Martin-Liberal J; Pérez E; García Del Muro X
    Expert Opin Investig Drugs; 2019 Jan; 28(1):39-50. PubMed ID: 30513001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current Molecular Targeted Therapies for Bone and Soft Tissue Sarcomas.
    Nakano K; Takahashi S
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29510588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ridaforolimus in advanced or metastatic soft tissue and bone sarcomas.
    Mita MM; Gong J; Chawla SP
    Expert Rev Clin Pharmacol; 2013 Sep; 6(5):465-82. PubMed ID: 23971829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histology-Specific Uses of Tyrosine Kinase Inhibitors in Non-gastrointestinal Stromal Tumor Sarcomas.
    Sethi TK; Keedy VL
    Curr Treat Options Oncol; 2016 Feb; 17(2):11. PubMed ID: 26931561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of adjuvant chemotherapy in the management of sarcomas in children.
    Donaldson SS
    Cancer; 1985 May; 55(9 Suppl):2184-97. PubMed ID: 3884137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The past, present, and future of cytotoxic chemotherapy and pathway-directed targeted agents for soft tissue sarcoma.
    Ryan CW; Desai J
    Am Soc Clin Oncol Educ Book; 2013; ():. PubMed ID: 23714556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic therapy for advanced soft-tissue sarcomas.
    Patel SR
    Curr Oncol Rep; 2002 Jul; 4(4):299-304. PubMed ID: 12044239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of advanced soft tissue sarcoma: conventional agents and promising new drugs.
    Wagner A
    J Natl Compr Canc Netw; 2007 Apr; 5(4):401-10. PubMed ID: 17442231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.